Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REDCENTRIC PLC Board/Management Information 2019

Aug 20, 2019

7875_rns_2019-08-20_f9d9552c-593b-4c4c-b62e-faff0199f723.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6398J

Redcentric PLC

20 August 2019

20 August 2019

Redcentric plc

Directorate change

Redcentric plc ("the Company") (AIM: RCN) today announces that, following five years in office, the Chairman, Chris Cole, has notified the Board of his intention to stand down once a suitable successor has been found. The Board will now commence a search process for a new chairman and Steve Vaughan, the Senior Independent Director, will lead the process. A further announcement regarding Chris' replacement will be made in due course.

Peter Brotherton, CEO, commented:

"On behalf of the Board and all at Redcentric, I would like to thank Chris for his counsel, guidance and leadership over the last five years and wish him all the best for the future. Chris has led the Board through a time of major change for the Company and leaves Redcentric in a stable position with a clearly defined strategy and opportunities for growth."

Enquiries:

Redcentric plc Via Tulchan Communications
Chris Cole, Chairman
Peter Brotherton, Chief Executive Officer
Numis Securities - NOMAD & Joint Broker +44 (0) 20 7260 1000
Simon Willis / Oliver Hardy
finnCap Ltd - Joint Broker +44 (0) 20 7220 0500
Stuart Andrews / Rhys Williams
Tulchan Communications +44 (0) 207 353 4200
James Macey White / Matt Low

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOACKKDNCBKKNFB